Troy E. Wilson, Ph.D., J.D.

Troy E. Wilson, Ph.D., J.D.

President and Chief Executive OfficeratKura Oncology· In proxies 2021–2025

Pay in FY2025Kura Oncology stock +19.3% the same year

Troy E. Wilson, Ph.D., J.D. was paid $4.7M in FY2025 (Dec). Kura Oncology stock rose 19.3% that year.

Pay$100 in the stock at the end of FY20 → $45
Pay is from the Summary Compensation Table of each Kura Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Kura OncologyPublic company · 5 yr
    • President and Chief Executive Officer2021 – Present · 5 yrStock in role -70%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?